C07C335/30

HYDROPERSULFIDE PRECURSORS
20210179553 · 2021-06-17 ·

A hydropersulfide precursor compound having the formula (I): formula (I) as defined in the specification. A process for preparing the hydropersulfide precursor, and a method of using the precursor to generate hydropersulfide are also described.

##STR00001##

HYDROPERSULFIDE PRECURSORS
20210179553 · 2021-06-17 ·

A hydropersulfide precursor compound having the formula (I): formula (I) as defined in the specification. A process for preparing the hydropersulfide precursor, and a method of using the precursor to generate hydropersulfide are also described.

##STR00001##

FUNGICIDAL ARYL AMIDINES

This disclosure relates to aryl amidines of Formula I and their use as fungicides.

##STR00001##

FUNGICIDAL ARYL AMIDINES

This disclosure relates to aryl amidines of Formula I and their use as fungicides.

##STR00001##

Hydropersulfide precursors

A hydropersulfide precursor compound having the formula (I): formula (I) as defined in the specification. A process for preparing the hydropersulfide precursor, and a method of using the precursor to generate hydropersulfide are also described. ##STR00001##

Hydropersulfide precursors

A hydropersulfide precursor compound having the formula (I): formula (I) as defined in the specification. A process for preparing the hydropersulfide precursor, and a method of using the precursor to generate hydropersulfide are also described. ##STR00001##

Substituted cyanoguanidines as oral anti-virals

This disclosure relates to: (a) compounds and salts of formula (I), formula (II), formula (III), and formula (IV), that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. ##STR00001##

Substituted cyanoguanidines as oral anti-virals

This disclosure relates to: (a) compounds and salts of formula (I), formula (II), formula (III), and formula (IV), that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. ##STR00001##